Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Atossa Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Actinium Pharmaceuticals Inc. (Delaware) November 30, 202376.0%
-
Atossa Therapeutics Inc. May 4, 202383.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 2, 2026 | Actinium Pharmaceuticals Inc. (Delaware) | Grant or award | +62,800 | — | — |
| May 12, 2026 | Atossa Therapeutics Inc. | Grant or award | +10,000 | — | — |
Questions about Richard I. Steinhart
What boards is Richard I. Steinhart on?
Richard I. Steinhart sits on the boards of Actinium Pharmaceuticals Inc. (Delaware) and Atossa Therapeutics Inc.
How long has Richard I. Steinhart served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.